While Mylan agreed to pay $465 million to resolve accusations it improperly classified EpiPens as a generic drug, the Canonsburg, Pa.-based drugmaker has yet to finalize the settlement with the ...

Mylan and federal investigators Thursday finalized a $465 million settlement of charges the drugmaker overcharged the government for the injection allergy medication EpiPen. Resolving an issue that ...

Mylan is bulking up programs that help patients pay for its EpiPen emergency allergy treatment after weathering heated criticism about an average cost that has climbed more than 600 percent over the ...

Mylan’s $465 million proposed settlement with CMS may not cover the amount of money it allegedly saved by improperly classifying EpiPens as a generic drug, according to research published Monday in ...

Mylan will make its generic to EpiPen available for purchase next week, according to npr. 1. The generic will cost half as much as EpiPen, carrying a list price of $300 for a two-pack. 2. In a ...

Two Democratic lawmakers are calling on the Federal Trade Commission to investigate if Mylan Pharmaceuticals violated antitrust laws to make sure that EpiPen dominated the market for the life-saving ...

Responding to national outrage over high prices, Mylan announced plans on Monday to launch a generic EpiPen at a 50% discount to the branded version of the life saving allergy treatment. Mylan (MYL) ...